Q3 2023 · 13F-HR
Carlyle Group Inc. (CG, CGABL)holdings as filed
Filed 2023-11-03 · accession 0000898432-23-000761
$2.31B
Reported value
25
Positions
2023-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 219798105 | QDEL | Quidelortho Corp | $910.1M | 39.5% | 12,460,183 | Common | SHARED |
| 98980F104 | GTM | ZoomInfo Technologies Inc | $596.6M | 25.9% | 36,377,293 | Common | SHARED |
| 55306N104 | MKSI | MKS Instrs Inc | $301.4M | 13.1% | 3,482,732 | Common | SHARED |
| G9440D103 | — | Vitru Ltd | $109.9M | 4.77% | 6,246,471 | Common | SHARED |
| 834203309 | SLNO | Soleno Therapeutics Inc | $67.4M | 2.92% | 2,293,562 | Common | SHARED |
| 374275105 | GETY | Getty Images Holdings Inc | $63.1M | 2.74% | 9,722,246 | Common | SHARED |
| 36165L108 | GDS | GDS Hldgs Ltd | $44.6M | 1.93% | 4,072,624 | Common | SHARED |
| 925050106 | VRNA | Verona Pharma Plc | $40.0M | 1.74% | 2,457,500 | Common | SHARED |
| 71722W107 | PHAT | Phathom Pharmaceuticals Inc | $36.2M | 1.57% | 3,496,808 | Common | SHARED |
| 43157M102 | — | Hillevax Inc | $24.7M | 1.07% | 1,838,486 | Common | SHARED |
| 75974E103 | — | Reneo Pharmaceuticals Inc | $20.5M | 0.89% | 2,698,957 | Common | SHARED |
| 92337R101 | VERA | Vera Therapeutics Inc | $19.7M | 0.85% | 1,438,155 | Common | SHARED |
| 78413P101 | SMHI | Seacor Marine Hldgs Inc | $18.2M | 0.79% | 1,314,164 | Common | SHARED |
| 46187W107 | INVH | Invitation Homes Inc | $15.1M | 0.66% | 477,500 | Common | SHARED |
| 229663109 | CUBE | CubeSmart | $8.4M | 0.36% | 220,500 | Common | SHARED |
| 85209E109 | — | Spruce Biosciences Inc | $6.5M | 0.28% | 2,896,518 | Common | SHARED |
| 471871103 | — | Jasper Therapeutics Inc | $6.1M | 0.26% | 8,761,891 | Common | SHARED |
| 20460L104 | SPWR | Complete Solaria Inc. | $5.1M | 0.22% | 2,495,879 | Common | SHARED |
| 83193E102 | EM | Smart Sh Global Ltd | $3.6M | 0.16% | 4,810,209 | Common | SHARED |
| 007002108 | TORCEUR | Adicet Bio Inc | $2.9M | 0.12% | 2,115,385 | Common | SHARED |
| 28202V108 | — | Effector Therapeutics Inc | $2.9M | 0.12% | 4,822,114 | Common | SHARED |
| 67022C106 | — | Nucana Plc | $2.0M | 0.09% | 3,333,333 | Common | SHARED |
| 68276W400 | — | Meta Data Limited | $325,656 | 0.01% | 314,400 | Common | SHARED |
| 30205M200 | XCUREUR | Exicure Inc | $199,962 | 0.01% | 281,636 | Common | SHARED |
| 608550208 | MTEMEUR | Molecular Templates Inc | $84,265 | 0.00% | 13,333 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.